Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus

Journal of Clinical Virology

Volumn 61, Issue 1, 2014, Pages 55-60

  Yu, Min Min ^a   Jiang, Qian ^b   Ji, Ying ^a   Wu, Kai Hua ^a   Ju, Li Li ^a   Tang, Xun ^a   Yang, Yong Feng ^a  

^a Nanjing Second Hospital   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

Author keywords

Hepatitis B virus; Lamivudine; Pregnancy; Telbivudine

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATINE KINASE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TELBIVUDINE; VIRUS DNA; ANTIVIRUS AGENT; THYMIDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CASE CONTROL STUDY; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DEVELOPMENT; GESTATIONAL AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RATE; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; VACCINE FAILURE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; HEPATITIS B, CHRONIC; INFANT; ISOLATION AND PURIFICATION; MALE; PERINATAL CARE; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PROCEDURES; TREATMENT OUTCOME; VIRUS LOAD; YOUNG ADULT;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LAMIVUDINE; MALE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; THYMIDINE; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84905117611     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.06.005     Document Type: Article

References (17)

1. Borgia G., Carleo M.A., Gaeta G.B., Gentile I. Hepatitis B in pregnancy. World J Gastroenterol 2012, 18:4677-4683.
2. Jonas M.M. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009, 29(Suppl. 1):133-139.
3. Guclu E., Karabay O. Choice of drugs in the treatment of chronic hepatitis B in pregnancy. World J Gastroenterol 2013, 19:1671-1672.
4. Yi W., Liu M., Cai H.D. Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. World J Gastroenterol 2012, 18:6645-6650.
5. Xu W.M., Cui Y.T., Wang L., Yang H., Liang Z.Q., Li X.M., et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009, 16:94-103.
6. Liu M.H., Sheng Y.J., Liu J.Y., Hu H.D., Zhang Q.F., Ren H. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Ann Saudi Med 2013, 33:169-176.
7. Yu M., Jiang Q., Ji Y., Jiang H., Wu K., Ju L., et al. The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus. Eur J Clin Microbiol Infect Dis 2012, 31:2211-2218.
8. Zou H.B., Chen Y., Zhang H., Duan Z.P., Li J., Zhuang H., et al. Prevention of hepatitis B virus vertical transmission: current situation and challenges. Zhonghua Gan Zang Bing Za Zhi 2010, 18:556-558.
9. Lai C., Gane E., Chao-Wei H., Thongsawat S., Wang Y., Chen Y. Two-year results from the GLOBE trial in patients with hepatitis B: greater clinical and antiviral efficacy for telbivudine (LdT) vs. lamivudine. Hepatology 2006, 44(4, Suppl. 1):222A.
10. Zhao S., Tang L., Fan X., Chen L., Zhou R., Dai X. Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review. Virol J 2010, 7:211.
11. Han Z., Shi Y., Zhu J., Chen Y., Yin F., Xia L., et al. Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis. J Viral Hepat 2013, 20(Suppl. 1):58-64.
12. Chan H.L., Chen Y.C., Gane E.J., Sarin S.K., Suh D.J., Piratvisuth T., et al. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naive patients with HBV-related decompensated cirrhosis. J Viral Hepat 2012, 19:732-743.
13. Ranger-Rogez S., Alain S., Denis F. Hepatitis viruses: mother to child transmission. Pathol Biol (Paris) 2002, 50:568-575.
14. Lin J., Liao S., Han J.L. Correlation between neonatal hepatitis B and maternal serum hepatitis B virus DNA copies. Pediatr Res 2000, 47:342.
15. Yin Y.Z., Zhou J., Zhang P.Z., Hou H.Y. Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission. Zhonghua Gan Zang Bing Za Zhi 2013, 21:105-110.
16. Han G.R., Cao M.K., Zhao W., Jiang H.X., Wang C.M., Bai S.F., et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011, 55:1215-1221.
17. Pan C.Q., Han G.R., Jiang H.X., Zhao W., Cao M.K., Wang C.M., et al. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol 2012, 10:520-526.